ArriVent BioPharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVBP and other ETFs, options, and stocks.About AVBP
Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, licensing, and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
AVBP Key Statistics
Stock Snapshot
The current ArriVent BioPharma(AVBP) stock price is $22.00, with a market capitalization of 962.27M. The stock trades at a price-to-earnings (P/E) ratio of -4.89.
On 2026-03-27, ArriVent BioPharma(AVBP) stock opened at $22.41, reached a high of —, and a low of —.
The ArriVent BioPharma(AVBP)'s current trading volume is 680, compared to an average daily volume of 429.5K.
In the last year, ArriVent BioPharma(AVBP) shares hit a 52-week high of $27.22 and a 52-week low of $15.47.
In the last year, ArriVent BioPharma(AVBP) shares hit a 52-week high of $27.22 and a 52-week low of $15.47.
Analyst ratings
100%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.